Why are clinical trials bound to boom?

New Technology platforms available:

• New therapeutic approaches for biological products(including peptides, RNA, a new generation of antibodies)
• Technological breakthroughs in protein expression systems
• Innovative chemistry platforms with a high potential to generate new families of molecules
• Advanced technologies could significantly improve chemical synthesis productivity (real-time monitoring, purification, fluid analysis, etc.).
• New biological systems with a high added value for translational medicine
• Enabling technologies based on the cellular approach
• New approaches to the drug repositioning
• IT tools to improve
• knowledge management,
• data mining (big data analysis),
• modelling and predictive analytics
• New biomarkers for :
• Predictivity of efficacy or safety;
• Development of surrogate markers;
• Diagnosis of diseases and stratification;
• Monitoring of disease progression.
• personalized medicine
• Validation of new therapeutic targets

New technologies to improve the administration and absorption of drugs:

• The RNA interference(RNAi)
• Administration of new vaccines
• Passage of the blood-brain barrier
• New innovative formulations
• Administration of organic products
• The oral bioavailability of proteins

Instruments or medical devices:

• New imaging technologies applicable in humans or in preclinical models
• Nanotechnologies
• New instruments making substantial improvements to the measures taken (in vivo or in vitro) or for assaying new parameters
• New diagnostic and prognostic approaches to improve the recruitment and monitoring of patients in clinical trials